annb0t
Top 20
Key Insights
Clinuvel Pharmaceuticals' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public The top 25 shareholders own 45% of the company 13% of Clinuvel Pharmaceuticals is held by insiders
Every investor in Clinuvel Pharmaceuticals Limited (ASX:CUV) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 54% to be precise, is individual investors. In...
>>> Read more: Institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV) shares but individual investors control 54% of the company
Clinuvel Pharmaceuticals' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public The top 25 shareholders own 45% of the company 13% of Clinuvel Pharmaceuticals is held by insiders
Every investor in Clinuvel Pharmaceuticals Limited (ASX:CUV) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 54% to be precise, is individual investors. In...
>>> Read more: Institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV) shares but individual investors control 54% of the company
